Concepedia

Sneha Ramakrishna

SR

22

Publications

4.6K

Citations

18

H-Index

2005

Active since

Affiliations

Stanford University(Current)

Center for Cancer Research

National Cancer Institute

University of Chicago

National Institutes of Health

Sneha Ramakrishna is an author at Stanford University specializing in medicine, developmental biology, and gene expression.

ORCID

Top concepts

Publications per year

2005–2024

22

Publications

22

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy

Terry J. Fry, Nirali N. Shah, Rimas J. Orentas et al. · Nature Medicine · 2017 · 1.3K citations · Full text

, , +9

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom et al. · Nature · 2022 · 737 citations · Full text

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 537 citations · Full text

The Forkhead Box m1 Transcription Factor Stimulates the Proliferation of Tumor Cells during Development of Lung Cancer

Il‐man Kim, Timothy Ackerson, Sneha Ramakrishna et al. · Cancer Research · 2006 · 343 citations

Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas

Adrienne H. Long, Steven L. Highfill, Yongzhi Cui et al. · Cancer Immunology Research · 2016 · 309 citations · Full text

Rows per page

1–5 of 22